Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Perry

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Breast Cancer Research : BCR|December 6, 2014
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypesKirsten M Timms, Victor Abkevich, Elisha Hughes, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
WGS to determine the extent of Clostridioides difficile transmission in a high incidence setting in North Wales in 2015David W Eyre, Robert Shaw, Helen Adams, et al.
Molecular Cancer Research : MCR|May 5, 2018
Biomarker Assessment of HR Deficiency, Tumor <i>BRCA1/2</i> Mutations, and <i>CCNE1</i> Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum MonotherapyEuan A Stronach, James Paul, Kirsten M Timms, et al.
Gynecologic Oncology|November 7, 2021
Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trialDarren R Hodgson, Jessica S Brown, Simon P Dearden, et al.
BMC Cancer|April 18, 2015
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer riskThaddeus Judkins, Benoît Leclair, Karla Bowles, et al.
Genes, Chromosomes & Cancer|May 24, 2023
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencingMelanie A Jones, Kirsten M Timms, Shanell Hatcher, et al.
Behaviour Research and Therapy|October 28, 2017
The ENGAGE study: Integrating neuroimaging, virtual reality and smartphone sensing to understand self-regulation for managing depression and obesity in a precision medicine modelLeanne M Williams, Adam Pines, Andrea N Goldstein-Piekarski, et al.
Cell|August 13, 2017
An Engineered orco Mutation Produces Aberrant Social Behavior and Defective Neural Development in AntsHua Yan, Comzit Opachaloemphan, Giacomo Mancini, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Myelin basic protein is an RNA chaperone in microglial nuclear retro-transportGuy Lam, Zhao Yang Xu, Adrien M Vaquié, et al.
BMJ Quality & Safety|June 26, 2026
Priorities for improving paediatric diagnosis: findings from a modified Delphi studyIrit R Rasooly, Katherine Wu, Meghan Galligan, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Breast Cancer Research : BCR|December 6, 2014
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypesKirsten M Timms, Victor Abkevich, Elisha Hughes, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
WGS to determine the extent of Clostridioides difficile transmission in a high incidence setting in North Wales in 2015David W Eyre, Robert Shaw, Helen Adams, et al.
Molecular Cancer Research : MCR|May 5, 2018
Biomarker Assessment of HR Deficiency, Tumor <i>BRCA1/2</i> Mutations, and <i>CCNE1</i> Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum MonotherapyEuan A Stronach, James Paul, Kirsten M Timms, et al.
Gynecologic Oncology|November 7, 2021
Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trialDarren R Hodgson, Jessica S Brown, Simon P Dearden, et al.
BMC Cancer|April 18, 2015
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer riskThaddeus Judkins, Benoît Leclair, Karla Bowles, et al.
Genes, Chromosomes & Cancer|May 24, 2023
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencingMelanie A Jones, Kirsten M Timms, Shanell Hatcher, et al.
Behaviour Research and Therapy|October 28, 2017
The ENGAGE study: Integrating neuroimaging, virtual reality and smartphone sensing to understand self-regulation for managing depression and obesity in a precision medicine modelLeanne M Williams, Adam Pines, Andrea N Goldstein-Piekarski, et al.
Cell|August 13, 2017
An Engineered orco Mutation Produces Aberrant Social Behavior and Defective Neural Development in AntsHua Yan, Comzit Opachaloemphan, Giacomo Mancini, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Myelin basic protein is an RNA chaperone in microglial nuclear retro-transportGuy Lam, Zhao Yang Xu, Adrien M Vaquié, et al.
BMJ Quality & Safety|June 26, 2026
Priorities for improving paediatric diagnosis: findings from a modified Delphi studyIrit R Rasooly, Katherine Wu, Meghan Galligan, et al.
Pageof 9